La selección del tipo de espéculo que se vaya a utilizar dependerá de los datos obtenidos en el interrogatorio a la paciente, así como de la edad y paridad. Antecedentes Patológicos 9. Antecedentes Familiares Interrogatorio por Aparatos y Sistemas Historia Pediátrica Historia y Examen Ginecológico   Métodos Previo interrogatorio ginecológico, se realizó citología exfoliativa cervico- vaginal (papanicolaou) a todas las pa- cientes que acudieron al.
|Published (Last):||25 October 2004|
|PDF File Size:||6.28 Mb|
|ePub File Size:||6.61 Mb|
|Price:||Free* [*Free Regsitration Required]|
Surgical approach to multifocal carcinoma in situ of the vulva. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus.
Foro casiMedicos 2006-2010 (Solo Lectura) Nuevo Foro en http://www.casimedicos.com/foro/
Frequency of invasive cancer in surgically excised vulvar lesions with intraepithelial neoplasia VIN 3. Treatment of intraepithelial carcinoma of the vulva by skin excision and graft. Am J Obstet Gynecol.
Effect of cigarette smoking on cervical epithelial immunity: The relevance of various vulvar epithelial changes in the early detection of squamous cell carcinoma of the vulva. Cofactors with human papillomavirus in a population-based study of vulvar cancer.
High-grade vulval intraepithelial neoplasia VIN 3: Epidermal thickness and skin appendage involvement in vulvar intraepithelial neoplasia. Am J Clin Pathol. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia VIN: Mene A, Buckley CH. Services on Demand Journal. Case-control study of cancer of the vulva.
Vulvar intraepithelial neoplasia: a current problem
Treatment of vulvar intraepithelial neoplasia with topical imiquimod. J Low Genit Tract Dis.
Laser ablation of surgical margins after excisional partial vulvectomy for VIN: However, a clinical lesion is always present. In situ and invasive vulvar cancer incidence trends to Genital warts, other sexually transmitted diseases, and vulvar cancer.
Intraepithelial carcinoma of the vulva. The high-risk human papilomavirus HR-HPV infection, human immunodeficiency virus HIV infection, smoking, cervical, vaginal and rectal intraepithelial neoplasia are considered to be high risk factors for development of VIN. A close follow-up of the patients is advised. N Engl J Med. Br J Obstet Gynaecol. Int J Gynecol Pathol. Inter-observer variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: Cytological evaluation correlates poorly with histological diagnosis of vulvar neoplasias.
Técnica de colocación del espéculo.
Wide local excision in the treatment of vulvar carcinoma in-situ: All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.
Vulvar intraepithelial neoplasia III: Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: Involvement of the vulval skin appendages by intraepithelial neoplasia.
Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Trends in vulvar neoplasia.
Topical imiquimod seems to be a promising treatment option. How to cite this article. Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of interrogayorio vulvar mucosa.
Examen con espéculo
Liberal vulvar biopsies under colposcopy guidance should be done. Presence and type of oncogenic papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma. VIN is a heterogeneous pathological entity with a usual type warty, basaloid and mixed and a differentiated type. The incidence of the disease is increasing, especially in young women.
Surgical excision and laser CO 2 vaporization are the most popular therapeutic modalities for VIN treatment, both with high rates of recurrence. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. Efficacy of a quadrivalent prophylactic human papillomavirus types 6, 11, 16, 18 L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: